Related references
Note: Only part of the references are listed.In Vitro Activity of NXL104 in Combination with β-Lactams against Klebsiella pneumoniae Isolates Producing KPC Carbapenemases
Andrea Endimiani et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
In vitro activity of the β-lactamase inhibitor NXL104 against KPC-2 carbapenemase and Enterobacteriaceae expressing KPC carbapenemases
Therese Stachyra et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
NXL104 combinations versus Enterobacteriaceae with CTX-M extended-spectrum β-lactamases and carbapenemases
David M. Livermore et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Genetic determinants for cfxA expression in Bacteroides strains isolated from human infections
Nuria Garcia et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Bacteroides: the good, the bad, and the nitty-gritty
Hannah M. Wexler
CLINICAL MICROBIOLOGY REVIEWS (2007)
Coincidence of bft and cfiA genes In a multi-resistant clinical isolate of Bacteroides fragilis
Gabriella Terhes et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2007)
Examination of cfiA-mediated carbapenem resistance in Bacteroides fragilis strains from a European antibiotic susceptibility survey
J. Soki et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2006)
Clostridium aldenense sp nov and Clostridium citroniae sp nov isolated from human clinical infections
Yumi A. Warren et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2006)
Relationship between penicillin-binding protein patterns and β-lactamases in clinical isolates of Bacteroides fragilis with different susceptibility to β-lactam antibiotics
S Píriz et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2004)
Share Paper
